Corvex, Inc. (MOVE) Form 424B5 — Oct 14, 2026
Corvex, Inc. (Nasdaq: MOVE) filed a 424B5 prospectus supplement establishing a $250 million at-the-market equity offering through Chardan Capital Markets, which will earn a 2.5% commission on gross proceeds, with net proceeds earmarked for working capital, general corporate purposes, infrastructure expansion, and commercialization. The program size is large relative to the company: with roughly 31.55 million shares outstanding and a last sale price of $9.15 (October 13, 2026), a full $250 million raise would imply dilution well in excess of 50%, and the filing explicitly warns sales may cause substantial dilution and pressure the stock price.
Key figures
- Gross Proceeds
- 250000000
- Offering Price
- $9.15 (last reported sale price October 13, 2026)
- Commission Rate
- 2.5% of gross proceeds
- Shares Outstanding
- 31552275
- Going Concern
- Yes
- Stock Range2026
- $5.10 to $24.46
- Program Expenses
- $225,000 estimated offering expenses excluding commissions
- Options Outstanding
- 8959011
- Warrants Outstanding
- 438547
- Series DConversion Shares
- 21791051
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.